Alert detail

LCD L37891: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test — Noridian

Policy ID: LCD-L37891Specialty: PulmonologyAdded: 6/5/2026Effective: June 29, 2023lcd
Routine

What changed

Envisia™ and Veracyte™ tests now supports compliance with updated rates accuracy.

Who’s affected: Pulmonology billing teams · Effective: June 29, 2023

Affected codes

Codes81554

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 3 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Pulmonology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Pulmonology audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Pulmonology— the week’s changes and deadlines, delivered to your inbox. No account required.